ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hereditary Transthyretin Amyloidosis (HATTR) Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-24H5622
Home | Market Reports | Health| Health Conditions
Global Hereditary Transthyretin Amyloidosis HATTR Market Insights Forecast to 2028
BUY CHAPTERS

Global Hereditary Transthyretin Amyloidosis (HATTR) Market Research Report 2025

Code: QYRE-Auto-24H5622
Report
June 2025
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Alnylam Pharmaceuticals
Akcea Therapeutics
Prothena
Lonis Pharmaceuticals
Eidos Therapeutics
Corino Therapeutics, Inc

Hereditary Transthyretin Amyloidosis (HATTR) Market

The global market for Hereditary Transthyretin Amyloidosis (HATTR) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Hereditary Transthyretin Amyloidosis (HATTR) is caused by the misfolding of protein monomers derived from the tetrameric protein transthyretin (TTR). Mutations in the gene for TTR frequently result in instability of TTR and subsequent fibril formation. HATTR can be sub-classified into familial amyloid polyneuropathy (FAP) and familial amyloid cardiomyopathy (FAC). The deposition of TTR amyloid fibrils in various tissues leads to ATTR, including Familial ATTR (hereditary ATTR) and non-hereditary ATTR types. Familial ATTR is a rare disorder with unequal distribution all around the world.
North American market for Hereditary Transthyretin Amyloidosis (HATTR) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Hereditary Transthyretin Amyloidosis (HATTR) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Hereditary Transthyretin Amyloidosis (HATTR) in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Hereditary Transthyretin Amyloidosis (HATTR) include Pfizer, Alnylam Pharmaceuticals, Akcea Therapeutics, Prothena, Lonis Pharmaceuticals, Eidos Therapeutics, Corino Therapeutics Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Hereditary Transthyretin Amyloidosis (HATTR), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hereditary Transthyretin Amyloidosis (HATTR).
The Hereditary Transthyretin Amyloidosis (HATTR) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hereditary Transthyretin Amyloidosis (HATTR) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hereditary Transthyretin Amyloidosis (HATTR) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Hereditary Transthyretin Amyloidosis (HATTR) Market Report

Report Metric Details
Report Name Hereditary Transthyretin Amyloidosis (HATTR) Market
Segment by Type
  • Oral
  • Subcutaneous Injection
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Alnylam Pharmaceuticals, Akcea Therapeutics, Prothena, Lonis Pharmaceuticals, Eidos Therapeutics, Corino Therapeutics Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Hereditary Transthyretin Amyloidosis (HATTR) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Hereditary Transthyretin Amyloidosis (HATTR) Market report?

Ans: The main players in the Hereditary Transthyretin Amyloidosis (HATTR) Market are Pfizer, Alnylam Pharmaceuticals, Akcea Therapeutics, Prothena, Lonis Pharmaceuticals, Eidos Therapeutics, Corino Therapeutics Inc

What are the Application segmentation covered in the Hereditary Transthyretin Amyloidosis (HATTR) Market report?

Ans: The Applications covered in the Hereditary Transthyretin Amyloidosis (HATTR) Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Hereditary Transthyretin Amyloidosis (HATTR) Market report?

Ans: The Types covered in the Hereditary Transthyretin Amyloidosis (HATTR) Market report are Oral, Subcutaneous Injection, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Subcutaneous Injection
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Perspective (2020-2031)
2.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Growth Trends by Region
2.2.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Hereditary Transthyretin Amyloidosis (HATTR) Historic Market Size by Region (2020-2025)
2.2.3 Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Region (2026-2031)
2.3 Hereditary Transthyretin Amyloidosis (HATTR) Market Dynamics
2.3.1 Hereditary Transthyretin Amyloidosis (HATTR) Industry Trends
2.3.2 Hereditary Transthyretin Amyloidosis (HATTR) Market Drivers
2.3.3 Hereditary Transthyretin Amyloidosis (HATTR) Market Challenges
2.3.4 Hereditary Transthyretin Amyloidosis (HATTR) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Revenue
3.1.1 Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Revenue (2020-2025)
3.1.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Players (2020-2025)
3.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Hereditary Transthyretin Amyloidosis (HATTR) Revenue
3.4 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Concentration Ratio
3.4.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hereditary Transthyretin Amyloidosis (HATTR) Revenue in 2024
3.5 Global Key Players of Hereditary Transthyretin Amyloidosis (HATTR) Head office and Area Served
3.6 Global Key Players of Hereditary Transthyretin Amyloidosis (HATTR), Product and Application
3.7 Global Key Players of Hereditary Transthyretin Amyloidosis (HATTR), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hereditary Transthyretin Amyloidosis (HATTR) Breakdown Data by Type
4.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Historic Market Size by Type (2020-2025)
4.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Type (2026-2031)
5 Hereditary Transthyretin Amyloidosis (HATTR) Breakdown Data by Application
5.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Historic Market Size by Application (2020-2025)
5.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2020-2031)
6.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2020-2025)
6.4 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2020-2031)
7.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2020-2025)
7.4 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2020-2031)
8.2 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2020-2025)
8.4 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2020-2031)
9.2 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2020-2025)
9.4 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2020-2031)
10.2 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2020-2025)
10.4 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.1.4 Pfizer Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Details
11.2.2 Alnylam Pharmaceuticals Business Overview
11.2.3 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.2.4 Alnylam Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025)
11.2.5 Alnylam Pharmaceuticals Recent Development
11.3 Akcea Therapeutics
11.3.1 Akcea Therapeutics Company Details
11.3.2 Akcea Therapeutics Business Overview
11.3.3 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.3.4 Akcea Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025)
11.3.5 Akcea Therapeutics Recent Development
11.4 Prothena
11.4.1 Prothena Company Details
11.4.2 Prothena Business Overview
11.4.3 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.4.4 Prothena Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025)
11.4.5 Prothena Recent Development
11.5 Lonis Pharmaceuticals
11.5.1 Lonis Pharmaceuticals Company Details
11.5.2 Lonis Pharmaceuticals Business Overview
11.5.3 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.5.4 Lonis Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025)
11.5.5 Lonis Pharmaceuticals Recent Development
11.6 Eidos Therapeutics
11.6.1 Eidos Therapeutics Company Details
11.6.2 Eidos Therapeutics Business Overview
11.6.3 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.6.4 Eidos Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025)
11.6.5 Eidos Therapeutics Recent Development
11.7 Corino Therapeutics Inc
11.7.1 Corino Therapeutics Inc Company Details
11.7.2 Corino Therapeutics Inc Business Overview
11.7.3 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.7.4 Corino Therapeutics Inc Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025)
11.7.5 Corino Therapeutics Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Alnylam Pharmaceuticals
Akcea Therapeutics
Prothena
Lonis Pharmaceuticals
Eidos Therapeutics
Corino Therapeutics, Inc
List of Tables
 Table 1. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Oral
 Table 3. Key Players of Subcutaneous Injection
 Table 4. Key Players of Others
 Table 5. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Region (2020-2025)
 Table 9. Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Region (2026-2031)
 Table 11. Hereditary Transthyretin Amyloidosis (HATTR) Market Trends
 Table 12. Hereditary Transthyretin Amyloidosis (HATTR) Market Drivers
 Table 13. Hereditary Transthyretin Amyloidosis (HATTR) Market Challenges
 Table 14. Hereditary Transthyretin Amyloidosis (HATTR) Market Restraints
 Table 15. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Players (2020-2025)
 Table 17. Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Transthyretin Amyloidosis (HATTR) as of 2024)
 Table 18. Ranking of Global Top Hereditary Transthyretin Amyloidosis (HATTR) Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Hereditary Transthyretin Amyloidosis (HATTR) Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Hereditary Transthyretin Amyloidosis (HATTR), Headquarters and Area Served
 Table 21. Global Key Players of Hereditary Transthyretin Amyloidosis (HATTR), Product and Application
 Table 22. Global Key Players of Hereditary Transthyretin Amyloidosis (HATTR), Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Type (2020-2025)
 Table 26. Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Type (2026-2031)
 Table 28. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Application (2020-2025)
 Table 30. Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Application (2026-2031)
 Table 32. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Pfizer Company Details
 Table 48. Pfizer Business Overview
 Table 49. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product
 Table 50. Pfizer Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025) & (US$ Million)
 Table 51. Pfizer Recent Development
 Table 52. Alnylam Pharmaceuticals Company Details
 Table 53. Alnylam Pharmaceuticals Business Overview
 Table 54. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product
 Table 55. Alnylam Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025) & (US$ Million)
 Table 56. Alnylam Pharmaceuticals Recent Development
 Table 57. Akcea Therapeutics Company Details
 Table 58. Akcea Therapeutics Business Overview
 Table 59. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product
 Table 60. Akcea Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025) & (US$ Million)
 Table 61. Akcea Therapeutics Recent Development
 Table 62. Prothena Company Details
 Table 63. Prothena Business Overview
 Table 64. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product
 Table 65. Prothena Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025) & (US$ Million)
 Table 66. Prothena Recent Development
 Table 67. Lonis Pharmaceuticals Company Details
 Table 68. Lonis Pharmaceuticals Business Overview
 Table 69. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product
 Table 70. Lonis Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025) & (US$ Million)
 Table 71. Lonis Pharmaceuticals Recent Development
 Table 72. Eidos Therapeutics Company Details
 Table 73. Eidos Therapeutics Business Overview
 Table 74. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product
 Table 75. Eidos Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025) & (US$ Million)
 Table 76. Eidos Therapeutics Recent Development
 Table 77. Corino Therapeutics Inc Company Details
 Table 78. Corino Therapeutics Inc Business Overview
 Table 79. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product
 Table 80. Corino Therapeutics Inc Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025) & (US$ Million)
 Table 81. Corino Therapeutics Inc Recent Development
 Table 82. Research Programs/Design for This Report
 Table 83. Key Data Information from Secondary Sources
 Table 84. Key Data Information from Primary Sources
 Table 85. Authors List of This Report


List of Figures
 Figure 1. Hereditary Transthyretin Amyloidosis (HATTR) Picture
 Figure 2. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type: 2024 VS 2031
 Figure 4. Oral Features
 Figure 5. Subcutaneous Injection Features
 Figure 6. Others Features
 Figure 7. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Case Studies
 Figure 10. Clinic Case Studies
 Figure 11. Others Case Studies
 Figure 12. Hereditary Transthyretin Amyloidosis (HATTR) Report Years Considered
 Figure 13. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Region: 2024 VS 2031
 Figure 16. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Players in 2024
 Figure 17. Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Transthyretin Amyloidosis (HATTR) as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Hereditary Transthyretin Amyloidosis (HATTR) Revenue in 2024
 Figure 19. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Country (2020-2031)
 Figure 21. United States Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Country (2020-2031)
 Figure 25. Germany Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Region (2020-2031)
 Figure 33. China Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Country (2020-2031)
 Figure 41. Mexico Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Country (2020-2031)
 Figure 45. Turkey Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Pfizer Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025)
 Figure 49. Alnylam Pharmaceuticals Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025)
 Figure 50. Akcea Therapeutics Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025)
 Figure 51. Prothena Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025)
 Figure 52. Lonis Pharmaceuticals Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025)
 Figure 53. Eidos Therapeutics Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025)
 Figure 54. Corino Therapeutics Inc Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2020-2025)
 Figure 55. Bottom-up and Top-down Approaches for This Report
 Figure 56. Data Triangulation
 Figure 57. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Transthyretin Stabilizer Market Research Report 2025
Global Drugs for Transthyretin Amyloid Cardiomyopathy Market Research Report 2024
Global Transthyretin Tetramer Stabilizer Drugs Market Research Report 2024
Global Treatment of Hereditary Transthyretin Amyloid Neuropathy ATTRv PN Market Research Report 2024
Global Familial Amyloid Polyneuropathy Therapeutic Market Research Report 2025
Transthyretin amyloid cardiomyopathy ATTR CM Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Transthyretin ELISA Kits Market Research Report 2024
Global Transthyretin TTR Modulators Market Research Report 2024
Global Antisense Oligonucleotides Drugs for ATTR Market Research Report 2024
Hereditary Amyloidosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Transthyretin Amyloidosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tafamidis Drugs Market Research Report 2024
Global Tafamidis API Market Research Report 2024
Global Rett Syndrome Market Insights Forecast to 2030
Global Primary Hyperoxaluria Treatment Market Research Report 2025
Global Transthyretin Market Research Report 2024
Global Iron Chelator Market Research Report 2024
Global Systemic Amyloidosis Market Research Report 2024
Global Ataxia telangiectasia AT Treatment Market Research Report 2025
Global Refsum Disease Treatment Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0I20198
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32E19705
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions